Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study.
Sonia Ares-GómezNarmeen MallahJacobo Pardo-SecoAlberto Malvar-PintosOlaia Pérez-MartínezMaría-Teresa Otero-BarrósNuria Súarez-GaicheMaria-Isolina Santiago-PérezJuan-Manuel González-PérezLuis-Ricardo López-PérezBenigno RosónRosa-María Alvárez-GilOlga-María Ces-OzoresVictoria Nartallo-PenasSusana Mirás-CarballalCarmen Rodríguez-TenreiroIrene Rivero-CalleAntonio SalasCarmen Durán-ParrondoFederico M TorresPublished in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2024)
Severe RSV infection in infants significantly increases short- to mid-term respiratory morbidity leading to an escalation in healthcare utilization (PHC/ES attendance) and medication prescriptions for up to 2 years afterward. Our approach could be useful in assessing the impact and cost-effectiveness of RSV prevention programs.